Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study

This publication has 31 references indexed in Scilit:

• Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review
  European Journal of Cardio-Thoracic Surgery, 1998
• Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
  Chest, 1997
• OPTIMIZING CHEMOTHERAPY AND RADIOTHERAPY IN LOCALLY ADVANCED NON–SMALL CELL LUNG CANCER
  Hematology/Oncology Clinics of North America, 1997
• Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935
  Cancer, 1996
• Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer
  The Annals of Thoracic Surgery, 1995
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
  Journal of Clinical Oncology, 1995
• Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
  The Annals of Thoracic Surgery, 1993
• Combined modality therapy for stage IIIA non-small cell carcinoma of the lung
  European Journal Of Cancer, 1993
• Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
  Journal of Clinical Oncology, 1992
• The Role of Surgery in N2 Lung Cancer
  Surgical Clinics of North America, 1987